Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45

Evolent Health initiated with an Overweight at KeyBanc

KeyBanc analyst Donald Hooker started Evolent Health with an Overweight rating and $23 price target. The company offers an attractive way to play the transformation of U.S. healthcare to value-based reimbursement, the analyst contends.

  • 25

    Sep

EVH Evolent Health
$15.65

-0.8 (-4.86%)

09/06/17
JEFF
09/06/17
NO CHANGE
Target $28
JEFF
Buy
Jefferies calls Evolent 'easy buy' after management meeting
Jefferies analyst Sean Dodge says Evolent Health shares are down 27% since the company's Q2 results on August 7 due to "overblown concerns" around 2018 revenue growth and use of proceeds from the primary share offering. After meeting with management, the analyst notes Evolent remains confident in its long-term outlook and that there are multiple near-term catalyst for the shares. Dodge believes Evolent's revenue will grow 25%-plus in 2018, even without another new client, and the $175M capital raise "foreshadows some big contract wins." He sees "little chance" of another secondary offering now that private equity ownership is mostly removed. Valuation makes Evolent "an easy buy," Dodge tells investors. He recommends buying the shares and keeps a Buy rating on the name with a $28 price target.
08/18/17
LEER
08/18/17
NO CHANGE
Target $32
LEER
Outperform
Leerink views CMS proposal as only modest negative for Evolent
Leerink analyst David Larsen says shares of Evolent Health traded lower this week after the Centers for Medicare & Medicaid Service announced a proposed rule that scales back the Comprehensive Care for Joint Replacement model and cancels the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive payment model which were slated to begin in January 2018. The move by CMS is a "modest negative" for Evolent because cardiac care and joint replacements tend to be high revenue and earnings drivers for hospitals, Larsen tells investors in a research note. The analyst, however, remains positive on the shares. He believes that with or without these two programs, the industry-wide shift towards value-based care will continue. Larsen keeps an Outperform rating on Evolent with a $32 price target.
08/18/17
JPMS
08/18/17
NO CHANGE
JPMS
Overweight
Evolent Health 29% selloff this week overdone, says JPMorgan
JPMorgan analyst Stephanie Davis views the 29% selloff this week in shares of Evolent Health following the company's Q2 results as overdone. The analyst says the pullback is a buying opportunity. Davis, while acknowledging that FY18 is a larger contract renewal year for Evolent, notes the Q2 results did not change her long term thesis. The analyst continues to believe in the company's "superior positioning to win in the shift to value based care." She keeps an Overweight rating on Evolent Health.
08/08/17
BARD
08/08/17
NO CHANGE
Target $35
BARD
Outperform
Evolent Health shares inexpensive relative to growth, says Baird
Baird analyst Matthew Gillmor noted Evolent Health reported better than expected Q2 results and raised guidance. He said the pipeline is deep with large opportunities, yet he believes investors may be confused with regards to 2018 visibility. The analyst said shares are simply too inexpensive relative to the company's organic growth rate and he expects its valuation will reset higher at some point. Gillmor reiterated his Outperform rating and $35 price target on Evolent Health shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

12:17
02/21/18
02/21
12:17
02/21/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/21/18
02/21
12:16
02/21/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPB

Campbell Soup

$44.73

-1.35 (-2.93%)

12:15
02/21/18
02/21
12:15
02/21/18
12:15
Options
Campbell Soup put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

12:15
02/21/18
02/21
12:15
02/21/18
12:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

IBKC

Iberiabank

$83.10

-1.2 (-1.42%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Hot Stocks
Federal Reserve approves Iberiabank purchase of Gibraltar Private Bank »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZN

Zion Oil & Gas

$4.47

0.43 (10.64%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Periodicals
Zion Oil & Gas shares deserve 'to crater,' TheStreetSweeper says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

, LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

12:07
02/21/18
02/21
12:07
02/21/18
12:07
Hot Stocks
Lionsgate slides as analyst cuts rating on competitive, cost concerns »

Bernstein analyst Todd…

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

DIS

Disney

$106.29

0.31 (0.29%)

FOX

21st Century Fox

$36.61

-0.43 (-1.16%)

FOXA

21st Century Fox

$37.13

-0.33 (-0.88%)

CMCSA

Comcast

$39.47

-0.32 (-0.80%)

CMCSK

Comcast

T

AT&T

$36.82

0.047 (0.13%)

TWX

Time Warner

$95.48

0.405 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 20

    Mar

  • 23

    Apr

ATVI

Activision Blizzard

$70.84

0.65 (0.93%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Periodicals
Activision's Sledgehammer founders leave studio, Kotaku reports »

Michael Condrey and Glen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

UNP

Union Pacific

$133.54

3.31 (2.54%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Hot Stocks
Union Pacific backs Q1 and FY18 volume goal of slightly positive »

Comments were made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TXN

Texas Instruments

$105.29

0.82 (0.78%)

12:01
02/21/18
02/21
12:01
02/21/18
12:01
Conference/Events
Texas Instruments management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 30

    May

BHGE

Baker Hughes

$27.48

1.04 (3.93%)

12:00
02/21/18
02/21
12:00
02/21/18
12:00
Options
Baker Hughes calls active as shares rally »

Baker Hughes calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

12:00
02/21/18
02/21
12:00
02/21/18
12:00
General news
FOMC minutes preview: »

FOMC minutes preview: the…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:55
02/21/18
02/21
11:55
02/21/18
11:55
Hot Stocks
Campbell expects $170M in cost synergies from Snyder's-Lance deal by FY22 »

CFO Anthony DiSilvestro…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

HBAN

Huntington Bancshares

$15.90

0.07 (0.44%)

11:50
02/21/18
02/21
11:50
02/21/18
11:50
Options
Call buyers in Huntington Bancshares »

Call buyers in Huntington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

11:50
02/21/18
02/21
11:50
02/21/18
11:50
General news
Treasury $15 B 2-year FRN reopening was weak »

Treasury $15 B 2-year FRN…

C

Citi

$77.50

1.0399 (1.36%)

11:47
02/21/18
02/21
11:47
02/21/18
11:47
Periodicals
Citi creates new position to supervise EMEA commodities banking, FT says »

According to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

, XLF

Financial Select Sector

$29.21

0.32 (1.11%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Technical Analysis
Technical Take: S&P 500 hits session highs at midday »

At time of writing the…

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

XLF

Financial Select Sector

$29.21

0.32 (1.11%)

XLB

S&P Select Materials SPDR

$60.73

0.52 (0.86%)

XLK

Technology Select Sector SPDR

$67.79

0.55 (0.82%)

XLRE

Real Estate SPDR

$30.23

-0.145 (-0.48%)

XLP

Consumer Staples Sector SPDR

$54.16

-0.18 (-0.33%)

SPY

SPDR S&P 500 ETF Trust

$273.35

1.945 (0.72%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.31

0.3 (0.83%)

, BIIB

Biogen

$287.45

-4.42 (-1.51%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Periodicals
Breaking Periodicals news story on Pfizer, Biogen, Roche »

Pfizer loses IPR…

PFE

Pfizer

$36.31

0.3 (0.83%)

BIIB

Biogen

$287.45

-4.42 (-1.51%)

RHHBY

Roche

$29.77

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 08

    Mar

  • 04

    Apr

  • 30

    May

SLCA

U.S. Silica

$26.56

-4.195 (-13.64%)

11:40
02/21/18
02/21
11:40
02/21/18
11:40
Options
Buy the dip call activity in Silica Holdings as shares tumble on earnings »

Buy the dip call activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Hot Stocks
Campbell expects Snyder's-Lance deal to deliver 'significant' cost synergies »

Says Snyder's-Lance…

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

PCRX

Pacira

$31.25

1.1 (3.65%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Recommendations
Pacira analyst commentary  »

Pacira Q4 sales momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Apr

AIDIF

Air Canada

11:35
02/21/18
02/21
11:35
02/21/18
11:35
Conference/Events
Air Canada management to meet with RBC Capital »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Options
25K Alerian MLP Mar 9th 10.5 puts trade for 20c on ISE »

25K Alerian MLP Mar 9th…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.